These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18361065)

  • 1. [Perioperative glycemic control by insulin glargine in type 2 diabetic patients].
    Li NS; Li WH; Wang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):109-11. PubMed ID: 18361065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT.
    Strojek K; Bebakar WM; Khutsoane DT; Pesic M; Smahelová A; Thomsen HF; Kalra S
    Curr Med Res Opin; 2009 Dec; 25(12):2887-94. PubMed ID: 19821654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
    Dailey G; Strange P
    Am J Manag Care; 2008 Jan; 14(1):25-30. PubMed ID: 18197742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA; Zinman B; Campos RV; Strack T;
    Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
    Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin glargine maintains equivalent glycemic control and better lipometabolic control than NPH insulin in type 1 diabetes patients who missed a meal.
    Rosak C; Jung R; Hofmann U
    Horm Metab Res; 2008 Aug; 40(8):544-8. PubMed ID: 18493882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal insulin therapy strategy is superior to premixed insulin therapy in the perioperative period blood glucose management.
    Huang QX; Lou FC; Wang P; Liu Q; Wang K; Zhang L; Zhu L; Yu S; Xu H; Wang Q; Zhang Y; Hou WK
    Chin Med J (Engl); 2013 Nov; 126(21):4030-6. PubMed ID: 24229669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk in diabetic patients treated with insulin glargine?
    Prescrire Int; 2010 Aug; 19(108):162-3. PubMed ID: 20939447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing major liver resection.
    Sato H; Lattermann R; Carvalho G; Sato T; Metrakos P; Hassanain M; Matsukawa T; Schricker T
    Anesth Analg; 2010 Jun; 110(6):1711-8. PubMed ID: 20375299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of insulin glargine in perioperative glucose control in type 2 diabetic patients.
    Kang H; Ahn KJ; Choi JY; Park HJ; Park SJ; Lee SK
    Eur J Anaesthesiol; 2009 Aug; 26(8):666-70. PubMed ID: 19367171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative glycaemic control in insulin-treated type 2 diabetes patients undergoing gastric bypass surgery.
    Cruijsen M; Koehestani P; Huttjes S; Leenders K; Janssen I; de Boer H
    Neth J Med; 2014 May; 72(4):202-9. PubMed ID: 24829176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes in a geriatric ward: efficacy and safety of new insulin analogs in very old inpatients.
    Franchin A; Corradin ML; Giantin V; Rossi F; Zanatta F; Attanasio F; Toffanello ED; Manzato E
    Aging Clin Exp Res; 2012 Jun; 24(3 Suppl):17-9. PubMed ID: 23160500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of long-acting insulin degludec on type 2 diabetic hemodialysis patients with poor glycemic control].
    Wada K; Wada Y; Tsuruoka S
    Nihon Jinzo Gakkai Shi; 2015; 57(5):872-7. PubMed ID: 26387380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.